Consumer telehealth · Weight-care / GLP-1
Eden
Eden is a consumer telehealth brand for medical weight loss and related wellness programs, connecting adults to clinicians and pharmacy fulfillment for GLP-1 care. It is not a hospital system.
Strong fit
- Adults comparing cash-pay telehealth programs for compounded GLP-1s with clear monthly prices
- Patients who want a clinician review and pharmacy delivery in one weight-loss program
- People comparing consumer weight-loss brands, not programs sold through employers
Weak fit
- Patients who need obesity care billed to insurance, with in-network coaching
- People who only want brand-name Wegovy or Zepbound and do not want to discuss compounded options
- Buyers looking for a clinic EHR or practice staffing, not consumer telehealth
Bottom line
Eden is worth using for adults who want a GLP-1 weight-loss program online with clear published prices for compounded medications. It suits people comfortable with clinician review and home delivery. People who want coaching alongside medication may prefer Found.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Eden, at tryeden.com, is a consumer telehealth company in Greenwood Village, Colorado, founded in 2023 by Adam McBride, Josh Khan, and Daniel Dietz. It has about 80 employees and claims more than 100,000 members.
It connects adults with independent clinicians for GLP-1 weight programs and related wellness care, and ships the medication. In 2025 it acquired Contigo Compounding, so it now runs its own 503A pharmacy.
Its published prices for compounded semaglutide and tirzepatide are easier to compare than memberships that bundle coaching and medication.
Results depend on clinician judgment, how well patients stay on treatment, and how well the pharmacy fills orders. Owning a pharmacy sets Eden apart, though patients should still check the label on every fill.
Among weight care companies we review, Eden scores just below Found and above Fridays and GobyMeds.
Found suits people who want coaching with their medication. Fridays suits those interested in longevity add-ons, and GobyMeds suits people who want the lowest published cash prices for GLP-1 bundles.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Form Health | 7.5 | 7.3 |
| Found | 7.4 | 7.2 |
| Calibrate | 7.3 | 7.1 |
| Eden | 7.3 | 7.2 |
| Fridays | 7.1 | 7.0 |
| Mochi Health | 7.0 | 6.6 |
| Nu Image Medical | 6.8 | 6.5 |
| Sesame | 6.8 | 6.7 |
| Henry Meds | 6.7 | 6.3 |
| GobyMeds | 6.6 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | A cash-pay membership or medication bundle for compounded and brand-name GLP-1s. Monthly prices are posted publicly. |
| What usually drives cost | The medication (semaglutide or tirzepatide), the dose, how many months you prepay, and whether brand-name drugs are prescribed. |
| What to ask before you buy | The full monthly cost at your expected dose, including clinician access, medication, and shipping. |
| Published pricing | Compounded plans are often advertised at a few hundred dollars a month, depending on the drug and how long you prepay. Confirm the price at checkout. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Eden to function | |
| An honest health and medication history for the clinician to review | Incomplete answers delay or block a prescription. |
| A clear budget for paying cash for medication and visits | Unexpected totals make people quit. |
| A plan to learn injections, or an oral option if one is offered | Patients who are not ready stall once the medication arrives. |
| A confirmed shipping address and a way to keep the medication cold | A failed delivery wastes medication. |
| A follow-up schedule you will keep | A single fill without check-ins gives weaker results. |
| What will maximize your value | |
| Finish labs or required screening before raising the dose | Skipping these steps raises safety risk. |
| Track weight, side effects, and missed doses every week for 90 days | Opening the app is not a result. |
| Use one pharmacy, and avoid getting prescriptions from two telehealth services | Two sources make dosing confusing. |
| Message the care team early about nausea or supply gaps | Side effects you do not report make people quit. |
| Check the price at each refill before autopay charges you | Dose changes change the monthly cost. |
| Deal-breakers | |
| You need obesity care covered by insurance and will not pay cash. | |
| A clinician decides a GLP-1 is not right for you. | |
| You cannot receive or store refrigerated medication safely. | |
| You will not complete required follow-up or screening. | |
| You expect a consumer telehealth brand to arrange hospital procedures. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Intake | 1-7 days. Answer the quiz and health history, and check eligibility. |
| 2 | Clinician review | 1-7 days. Approval, or other options. |
| 3 | First shipment | 2-10 days. The pharmacy fills and delivers the order. |
| 4 | Dose changes and follow-up | 1-6 months. Adjust the dose and check in. |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.
